ClinicalTrials.gov
public full text
Public Domain
Duloxetine vs Placebo in the Treatment of General Anxiety
To see if duloxetine 60 to 120 mg once daily (QD) is better than placebo in the treatment of generalized anxiety disorder (GAD).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Duloxetine for the Treatment of Generalized Anxiety Disorder#857079
- Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID)#1161451
- Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome#1150546
- Double Blind Placebo Control Opipramol-Baclofen Treatment for Addiction#896593
- A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia#864946
Record · ID 1103378
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive